| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |